Last 12 months
Inside the activity.
5 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2022 Filed Dec 30, 2022 20:29 UTC Amendment |
Waters John JDirector
|
GrantRestricted Stock | 21,851 | $3.89 | $85,000.39 |
DisclosureSEC source: 0001486189-22-000020 · primary_doc.xml · nonDerivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,851 Read SEC document |
| May 05, 2022 Filed May 11, 2022 16:46 UTC |
Hosseinion WarrenDirector · President
|
GiftCommon Stock | 102,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001486189-22-000013 · primary_doc.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,048,675 Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC |
Schimmel LawrenceChief Medical Information Off
|
OtherWarrant · Derivative | 9,799 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · derivative · entry 4 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,799 shares Expires 2022-07-31 F2 · security: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F2 · derivative.exercise_price: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F2 · derivative.expiration_date: Warrant No. 2019A-14 issued on 12/31/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC |
Schimmel LawrenceChief Medical Information Off
|
ConversionConvertible Promissory Note · Derivative | 30,375.35 | $100,000.00 Strike: $1.55 | $3,037,535,000.00 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · derivative · entry 3 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,597 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F1 · derivative.exercise_price: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. F1 · derivative.expiration_date: Convertible Promissory Note originally issued on 11/19/2019 and amended by (i) Assignment and Consent Agreement and Amendment to Subscription Agreement, Convertible Debenture and Warrant dated 9/30/2020 and (ii) Second Amendment to Convertible Promissory Note dated 1/29/2021. Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC |
Schimmel LawrenceChief Medical Information Off
|
OtherCommon Stock | 9,799 | $1.55 | $15,188.45 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · nonDerivative · entry 2 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,444 Read SEC document |
| April 02, 2022 Filed Aug 2, 2022 18:26 UTC |
Schimmel LawrenceChief Medical Information Off
|
ConversionCommon Stock | 19,597 | $1.55 | $30,375.35 |
DisclosureSEC source: 0001062993-22-017071 · form4.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:03 UTC |
Young Matthew StephenDirector
|
GrantCommon Stock | 42,134,210 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-009714 · form4.xml · nonDerivative · entry 1 Young Matthew Stephen · CIK 0001920043 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Premier Macy Management Holdings, LLC Disclosed balance after: 42,134,210 F1 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:46 UTC |
Vo Thomas T.Director · Chairman, CEO
|
GrantCommon Stock | 267,728,389 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-009698 · form4.xml · nonDerivative · entry 1 Vo Thomas T. · CIK 0001919945 · Director · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Micro Hospital Holdings LLC Disclosed balance after: 267,728,389 F1 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. F2 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holdings LLC, the direct owner of the securities of the registrant reported herein. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:46 UTC |
Chang Michael L.Chief Medical Officer
|
GrantCommon Stock | 12,008,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-009699 · form4.xml · nonDerivative · entry 1 Chang Michael L. · CIK 0001919832 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Michael Chang PLLC Disclosed balance after: 12,008,523 F1 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 14:21 UTC |
Barnett AndrewEVP of Corp Development
|
GrantOfficer Stock Option (right to buy) · Derivative | 150,000 | $2.75 Strike: $2.75 | $412,500.00 |
DisclosureSEC source: 0001486189-22-000003 · primary_doc.xml · derivative · entry 1 Barnett Andrew · CIK 0001853463 · EVP of Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 14:25 UTC |
Luqman Elisa VChief Legal Officer - SEC
|
GrantOfficer Stock Option (right to buy) · Derivative | 150,000 | $2.75 Strike: $2.75 | $412,500.00 |
DisclosureSEC source: 0001486189-22-000004 · primary_doc.xml · derivative · entry 1 Luqman Elisa V · CIK 0001486189 · Chief Legal Officer - SEC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,106 Underlying: Common Stock · 150,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:42 UTC |
Creem MitchellDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 182,000 | $2.75 Strike: $2.75 | $500,500.00 |
DisclosureSEC source: 0001486189-22-000008 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,120 Underlying: Common Stock · 182,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:40 UTC |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 182,000 | $2.75 Strike: $2.75 | $500,500.00 |
DisclosureSEC source: 0001486189-22-000007 · primary_doc.xml · derivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,824 Underlying: Common Stock · 182,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:34 UTC |
Schimmel LawrenceChief Medical Information Off
|
GrantOfficer Stock Option (right to buy) · Derivative | 200,000 | $2.75 Strike: $200,000.00 | $550,000.00 |
DisclosureSEC source: 0001486189-22-000006 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Information Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,684 Underlying: Common Stock · 200,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:18 UTC |
STERNBERG FREDERICKPresident of subsidiary
|
GrantOfficer Stock Option (right to buy) · Derivative | 75,000 | $2.75 Strike: $2.75 | $206,250.00 |
DisclosureSEC source: 0001486189-22-000002 · primary_doc.xml · derivative · entry 1 STERNBERG FREDERICK · CIK 0001268543 · President of subsidiary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:29 UTC |
Bowen MichaelChief Financial Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 200,000 | $2.75 Strike: $2.75 | $550,000.00 |
DisclosureSEC source: 0001486189-22-000005 · primary_doc.xml · derivative · entry 1 Bowen Michael · CIK 0001856020 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Apr 8, 2022 18:12 UTC |
Hosseinion WarrenDirector · President
|
GrantDirector Stock Option (right to buy) · Derivative | 1,900,000 | $2.75 Strike: $2.75 | $5,225,000.00 |
DisclosureSEC source: 0001486189-22-000001 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723,590 Underlying: Common Stock · 1,900,000 shares Expires 2032-04-01 Read SEC document |
| April 01, 2022 Filed Jun 14, 2022 19:36 UTC Amendment |
Vo Thomas T.Director · Chief Executive Officer
Micro Hospital Holding LLC10% owner
|
GrantCommon Stock | 267,706,960 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-014849 · form4a.xml · nonDerivative · entry 1 Vo Thomas T. · CIK 0001919945 · Director · Chief Executive Officer Micro Hospital Holding LLC · CIK 0001919448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Micro Hospital Holding LLC Disclosed balance after: 267,706,960 F1 · shares: This amendment is filed to correct the number of shares of the registrant issued to Micro Hospital Holding LLC in the merger. F2 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. F3 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein. Read SEC document |
| April 01, 2022 Filed Aug 5, 2022 15:44 UTC Amendment |
Vo Thomas T.Director · Chairman, CEO · 10% owner
Micro Hospital Holding LLC10% owner
|
GrantCommon Stock | 267,322,776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-017378 · form4a.xml · nonDerivative · entry 1 Vo Thomas T. · CIK 0001919945 · Director · Chairman, CEO · 10% owner Micro Hospital Holding LLC · CIK 0001919448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Micro Hospital Holding LLC Disclosed balance after: 267,322,776 F1 · kind: This amendment is filed to correct the number of shares of the registrant issued to Micro Hospital Holdings LLC in the merger. F2 · price: At the closing of the business combination pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on February 14, 2022, as supplemented, the reporting person received 3.571428575 shares of Common Stock of the Issuer in exchange for each membership interest in Nutex Health Holdco LLC. F3 · ownership.nature: Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein. Read SEC document |
| February 25, 2021 Filed Dec 21, 2021 18:10 UTC |
Hosseinion WarrenDirector · Chief Executive Officer
|
OtherCommon Stock | 894,209 | $2.04 | $1,824,186.36 |
DisclosureSEC source: 0001486189-21-000013 · primary_doc.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151,563 F1 · kind: Acquired as per merger exchange. Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 11:11 UTC |
Luqman Elisa VDirector · Chief Financial Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 400,000 | $1.61 Strike: $1.61 | $644,000.00 |
DisclosureSEC source: 0001486189-21-000001 · primary_doc.xml · derivative · entry 2 Luqman Elisa V · CIK 0001486189 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,106 Underlying: Common Stock · 400,000 shares Expires 2031-01-28 F2 · derivative.exercise_date: Upon certain milestones Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 11:11 UTC |
Luqman Elisa VDirector · Chief Financial Officer
|
GrantCommon Stock | 1,500 | $1.61 | $2,415.00 |
DisclosureSEC source: 0001486189-21-000001 · primary_doc.xml · nonDerivative · entry 1 Luqman Elisa V · CIK 0001486189 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,870 F1 · balance_after: Includes 1,370 shares owned by Spouse Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 19:55 UTC |
Hosseinion WarrenDirector · 10% owner
|
Grant600,000 · Derivative | 600,000 | $1.61 Strike: $1.61 | $966,000.00 |
DisclosureSEC source: 0001486189-21-000004 · primary_doc.xml · derivative · entry 2 Hosseinion Warren · CIK 0001438327 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 600,000 shares Expires 2031-01-27 F1 · derivative.expiration_date: Vested upon closing of merger. Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 19:49 UTC |
Schimmel LawrenceChief Executive Officer
|
GrantCommon Stock | 107,692 | $0.65 | $69,999.80 |
DisclosureSEC source: 0001486189-21-000003 · primary_doc.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,047 Read SEC document |
| January 28, 2021 Filed Feb 3, 2021 19:41 UTC |
Creem MitchellDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000002 · primary_doc.xml · derivative · entry 2 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,120 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25% ,fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| January 28, 2021 Filed Feb 4, 2021 19:05 UTC |
Meiri DavidDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000006 · primary_doc.xml · derivative · entry 2 Meiri David · CIK 0001793394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,120 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| January 28, 2021 Filed Feb 4, 2021 18:58 UTC |
Breslin Terence MartinDirector · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000005 · primary_doc.xml · derivative · entry 2 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,120 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| January 28, 2021 Filed Feb 5, 2021 15:27 UTC |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $1.61 Strike: $1.61 | $72,450.00 |
DisclosureSEC source: 0001486189-21-000007 · primary_doc.xml · derivative · entry 2 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,800 Underlying: Common Stock · 45,000 shares Expires 2028-01-28 F1 · derivative.exercise_date: Quarterly 25%, fully vested upon change in control, fully vested upon closing of merger. Read SEC document |
| January 28, 2021 Filed Dec 21, 2021 18:26 UTC |
Fawcett MarkDirector
|
OtherCommon Stock | 268,263 | $2.04 | $547,256.52 |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · nonDerivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,259 F1 · kind: Acquired as per Merger Transaction exchange Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 14:02 UTC Amendment |
Hosseinion WarrenDirector
|
PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000017 · primary_doc.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,521 F1 · balance_after: Does not include 200,000 options and 21,590 warrants previously reported. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:34 UTC |
Meiri DavidDirector
|
PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000015 · primary_doc.xml · nonDerivative · entry 1 Meiri David · CIK 0001793394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,627 F1 · balance_after: Does not include 85,120 options to purchase common shares, previously reported. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:31 UTC |
Creem MitchellDirector
|
PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000014 · primary_doc.xml · nonDerivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 F1 · balance_after: Does not include 85,120 options to purchase common shares, previously reported. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:24 UTC |
Breslin Terence MartinDirector · 10% owner
|
PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000013 · primary_doc.xml · nonDerivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724,496 F1 · balance_after: Does not include 85,120 options previously reported. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:18 UTC |
Waters John JDirector
|
PurchaseCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000012 · primary_doc.xml · nonDerivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,746 F1 · balance_after: Does not include 102,800 options, 43,986 convertible options and 27,497 warrants previously reported. Read SEC document |
| August 12, 2020 Filed Sep 9, 2020 13:05 UTC |
Hosseinion WarrenDirector
|
Disposition to issuerCommon Stock | 31,746 | $20,000.00 | $634,920,000.00 |
DisclosureSEC source: 0001486189-20-000011 · primary_doc.xml · nonDerivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,521 F1 · balance_after: Does not include 200,000 options and 21,590 warrants previously reported Read SEC document |
| August 05, 2020 Filed Dec 21, 2021 18:26 UTC |
Fawcett MarkDirector
|
PurchaseDirector Stock Option (right to buy) · Derivative | 85,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · derivative · entry 2 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 85,120 shares Expires not disclosed F2 · derivative.exercise_price: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · price: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · derivative.exercise_date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · derivative.expiration_date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 Read SEC document |
| July 13, 2020 Filed Sep 29, 2020 16:15 UTC |
Margolin JacobDirector
|
PurchaseCommon Stock | 228,346 | $179,800.00 | $41,056,610,800.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · nonDerivative · entry 2 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,998 F1 · balance_after: (1) Does not include 30,000 options reported on Table II. Read SEC document |
| June 30, 2020 Filed Sep 9, 2020 13:41 UTC |
Schimmel LawrenceChief Executive Officer
|
PurchaseCommon Stock | 44,828 | $65,000.00 | $2,913,820,000.00 |
DisclosureSEC source: 0001486189-20-000016 · primary_doc.xml · nonDerivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,355 F1 · balance_after: Does not include 36,288 options to purchase common shares, 5,465 convertible options and 3,415 warrants previously reported. Read SEC document |
| June 30, 2020 Filed Sep 29, 2020 16:15 UTC |
Margolin JacobDirector
|
PurchaseCommon Stock | 31,034 | $45,000.00 | $1,396,530,000.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · nonDerivative · entry 1 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,652 F1 · balance_after: (1) Does not include 30,000 options reported on Table II. Read SEC document |
| May 11, 2020 Filed Jun 15, 2020 16:54 UTC |
Luqman Elisa VDirector · Chief Financial Officer
|
GrantDirector Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000003 · primary_doc.xml · derivative · entry 1 Luqman Elisa V · CIK 0001486189 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,106 Underlying: Common Stock · 50,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 16, 2020 17:43 UTC |
Meiri DavidDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000006 · primary_doc.xml · derivative · entry 1 Meiri David · CIK 0001793394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 16, 2020 13:23 UTC |
Waters John JDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000005 · primary_doc.xml · derivative · entry 1 Waters John J · CIK 0001296807 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,283 Underlying: Common Stock · 50,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 16, 2020 13:19 UTC |
Fawcett MarkDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000004 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,718 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 17, 2020 18:56 UTC |
Hosseinion WarrenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000007 · primary_doc.xml · derivative · entry 1 Hosseinion Warren · CIK 0001438327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,590 Underlying: Common Stock · 100,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 18, 2020 14:16 UTC |
Creem MitchellDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000009 · primary_doc.xml · derivative · entry 1 Creem Mitchell · CIK 0001572821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 18, 2020 14:13 UTC |
Schimmel LawrenceChief Medical Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000008 · primary_doc.xml · derivative · entry 1 Schimmel Lawrence · CIK 0001793716 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,168 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Jun 23, 2020 14:09 UTC |
Breslin Terence MartinDirector · 10% owner
|
GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000010 · primary_doc.xml · derivative · entry 1 Breslin Terence Martin · CIK 0001793402 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 11, 2020 Filed Sep 29, 2020 16:15 UTC |
Margolin JacobDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001793452-20-000001 · primary_doc.xml · derivative · entry 3 Margolin Jacob · CIK 0001793452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| January 27, 2020 Filed Apr 24, 2020 17:10 UTC |
Luqman Elisa VDirector · Chief Financial Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 5,400 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000001 · primary_doc.xml · derivative · entry 2 Luqman Elisa V · CIK 0001486189 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: Common Stock · 5,400 shares Expires 2030-01-27 Read SEC document |
| January 27, 2020 Filed Apr 24, 2020 17:10 UTC |
Luqman Elisa VDirector · Chief Financial Officer
|
GrantOfficer Stock Option (right to buy) · Derivative | 61,706 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000001 · primary_doc.xml · derivative · entry 1 Luqman Elisa V · CIK 0001486189 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,706 Underlying: Common Stock · 61,706 shares Expires 2030-01-27 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.